Sean Ervin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sean Ervin has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Alhassan Abdul-Mumin
School of Medicine and Health Sciences, University for Development Studies, P.O. Box 1883, Tamale, Ghana
1 shared publicationAnthony Amponsem
School of Medicine and Health Sciences, University for Development Studies, P.O. Box 1883, Tamale, Ghana
1 shared publication- Bruno Emmanuel Correia
Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
1 shared publication - Charles-Adrien Richard
VIM-INRA-Université Paris-Saclay, Jouy-en-Josas, France
1 shared publication - Che Yang
École Polytechnique Fédérale de Lausanne
1 shared publication Chi-I Chiang
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA
1 shared publication
Latest Publications
- 15 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6492) , 730-+
De novo protein design enables the precise induction of RSV-neutralizing antibodies
TopoBuilding precision vaccines: To induce strong and targeted neutralizing antibody (nAb) responses against vaccine targets, one strategy has been to use computationally designed immunogens. However, the structural complexity of many known neutralization epitopes has posed a major challenge for the design of accurate epitope mimetics. Sesterhenn et al. created a protein design algorithm called TopoBuilder to design scaffolds for irregular and discontinuous neutralization epitopes. As a proof of principle, the authors generated epitope-focused immunogens based on the prefusion conformation of the respiratory syncytial virus (RSV) fusion protein. When these immunogens were used to vaccinate mice and nonhuman primates in RSV infection models, they generated targeted nAb responses to RSV and boosted site-specific nAb responses in heterologous prime-boost vaccination schemes. Science , this issue p. eaay5051
- 15 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6492) , 730-+
De novo protein design enables the precise induction of RSV-neutralizing antibodies
TopoBuilding precision vaccines: To induce strong and targeted neutralizing antibody (nAb) responses against vaccine targets, one strategy has been to use computationally designed immunogens. However, the structural complexity of many known neutralization epitopes has posed a major challenge for the design of accurate epitope mimetics. Sesterhenn et al. created a protein design algorithm called TopoBuilder to design scaffolds for irregular and discontinuous neutralization epitopes. As a proof of principle, the authors generated epitope-focused immunogens based on the prefusion conformation of the respiratory syncytial virus (RSV) fusion protein. When these immunogens were used to vaccinate mice and nonhuman primates in RSV infection models, they generated targeted nAb responses to RSV and boosted site-specific nAb responses in heterologous prime-boost vaccination schemes. Science , this issue p. eaay5051
- Open Access
- 3 May 2015
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2015, 1-8
Treatment Outcome of Severe Acute Malnutrition Cases at the Tamale Teaching Hospital
Objective.This study investigated the treatment outcomes and determinant factors likely to be associated with recovery rate.Methods.A retrospective chart review (RCR) was performed on 348 patients who were enrolled in the outpatient care (OPC) during the study period.Results.Of the 348 cases, 33.6% recovered (having MUAC125 mm), 49.1% defaulted, and 11.5% transferred to other OPC units to continue with treatment. There were 187 (53.7%) males and 161 (46.3%) females with severe malnutrition. The average weight gain rate was 28 g/kg/day. Controlling for other factors, patients who completed the treatment plan had 3.2 times higher probability of recovery from severe acute malnutrition (SAM) as compared to patients who defaulted (adjusted odds ratio (AOR) = 3.2, 95% CI = 1.9, 5.3, and). The children aged 24–59 months had 5.8 times higher probability of recovery from SAM as compared to children aged 6–11 months (AOR = 5.8, 95% CI = 2.5, 10.6, and).Conclusions.Cure rate was low and the default rate was quite high. Children who were diagnosed as having marasmus on admission stayed longer before recovery than their kwashiorkor counterparts. Younger children were of greater risk of nonrecovery.- 3 May 2015
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2015, 1-8
Open AccessTreatment Outcome of Severe Acute Malnutrition Cases at the Tamale Teaching Hospital
Objective.This study investigated the treatment outcomes and determinant factors likely to be associated with recovery rate.Methods.A retrospective chart review (RCR) was performed on 348 patients who were enrolled in the outpatient care (OPC) during the study period.Results.Of the 348 cases, 33.6% recovered (having MUAC125 mm), 49.1% defaulted, and 11.5% transferred to other OPC units to continue with treatment. There were 187 (53.7%) males and 161 (46.3%) females with severe malnutrition. The average weight gain rate was 28 g/kg/day. Controlling for other factors, patients who completed the treatment plan had 3.2 times higher probability of recovery from severe acute malnutrition (SAM) as compared to patients who defaulted (adjusted odds ratio (AOR) = 3.2, 95% CI = 1.9, 5.3, and). The children aged 24–59 months had 5.8 times higher probability of recovery from SAM as compared to children aged 6–11 months (AOR = 5.8, 95% CI = 2.5, 10.6, and).Conclusions.Cure rate was low and the default rate was quite high. Children who were diagnosed as having marasmus on admission stayed longer before recovery than their kwashiorkor counterparts. Younger children were of greater risk of nonrecovery.